This website google translation is automatic. Our information refers to health and other services in the UK. Before changing any care or treatment, please talk to your doctor about what you have read here. We hope you find the translated pages useful.
News
News
Update on NICE Decision for Continued Access to risdiplam (Evrysdi) and nusinersen (Spinraza).
News
Treatments & Research
First NICE committee meeting for continued access to Spinraza and Risdiplam
Advocacy
News
The Power of Real-World Data: Why Patients’ Experiences Prove the Case for SMA Drugs
Advocacy
News
Beyond Mobility: Why Holding the Line is a Major Win in SMA Treatment
Advocacy
News
Landmark victory as Spinraza becomes routinely available on the NHS in Scotland
Advocacy
Information
News
Treatments & Research
The Scottish Government will be adding SMA to their newborn screening programme
Advocacy
News
SMA MTA External Assessment Report is now live
Advocacy
News
Government U-Turns on Key Disability Benefit Cuts After Backlash
News
Hattie and James share their son Theo’s story about his SMA diagnosis
Advocacy
News
Treatments & Research
The National Institute for Health and Care research (NIHR) release ‘research call’